Effect of Thyroid Hormone on Gastric Mucus Secretion Around Indomethacin Induced Gastric Ulcers in Rats

2007 ◽  
Vol 7 (4) ◽  
pp. 678-681 ◽  
Author(s):  
F.S. Oluwole ◽  
M.T. Saka .
Molecules ◽  
2020 ◽  
Vol 25 (23) ◽  
pp. 5623
Author(s):  
Young-Sik Kim ◽  
Ji Hyeon Lee ◽  
Jungbin Song ◽  
Hocheol Kim

Inulae Flos, the flower of Inula britannica L., is used as a dietary supplement, beverage, and medicine in East Asia. In this study, we evaluated the gastroprotective effects of Inulae Flos extract (IFE) against gastric mucosal lesions induced by hydrochloric acid (HCl)/ethanol in rats and explored its potential mechanisms by measuring antioxidant enzyme activity, mucus secretion, and prostaglandin E2 (PGE2) levels. Pretreatment with IFE at doses of 100 and 300 mg/kg significantly inhibited gastric lesions in HCl/ethanol-treated rats. IFE increased the activities of superoxide dismutase and catalase and the levels of glutathione and PGE2 in gastric tissues. The administration of IFE also significantly increased the gastric wall mucus contents in HCl/ethanol-induced gastric lesions. These findings suggest that IFE has gastroprotective effects against HCl/ethanol-induced gastric lesions and exerts these effects through increased antioxidant levels and gastric mucus secretion. Inulae Flos may be a promising agent for the prevention and treatment of gastritis and gastric ulcers.


2020 ◽  
Vol 5 (1) ◽  
pp. 93-99
Author(s):  
Joseph Fleurie Emakoua ◽  
Tchokomeni Gael Siwe ◽  
Paul Vernyuy Tan ◽  
Andre Perfusion Amang ◽  
Charle Banenzoue ◽  
...  

This study evaluated the in vivo curative and antacid effects of MY41g clay on chronic and “unhealed" gastric ulcers in rats. Chronic gastric ulcers were induced by injecting 0.05 mL of acetic acid (30%) into the stomach wall. From day 5-14 after induction of ulcers, rats were treated daily with MY41g clay (125 and 250 mg/kg). For “Unhealed" gastric ulcers, from day 5-18 rats received MY41g clay orally concomitantly with indomethacin (1 mg/kg/day) subcutaneously. The ulcer index, percentage of healing, mucus secretion, histological parameters, oxidative stress parameters and gastric acidity were assessed. Treatment with clay solution for 10 days resulted in accelerated spontaneous healing of chronic gastric ulcers (83.69-90.2%). However, indomethacin administration did not induce significant variations in the percentage of healing (89.23-91.66%) in rats. For both ulcer models performed, ulcer healing was accompanied by a significant increase (p<0.001) of mucus secretion at the highest dose. Clay increased concentrations of antioxidant enzymes and decreased gastric acidity and lipid peroxidation. Administration of clay accelerated the spontaneous healing of both induction models. The mode of action of the clay could involve increased gastric mucus production, gastric mucosal re-epithelialization, improved antioxidant status and gastric acid neutralization. MY41g clay can be used as antacids in the ulcer treatment regime.


1996 ◽  
Vol 51 (7-8) ◽  
pp. 563-569 ◽  
Author(s):  
M. Reyes ◽  
C. Martín ◽  
C. Alarcón de la Lastra ◽  
J. Trujillo ◽  
M. V. Toro ◽  
...  

Abstract Investigations were carried out to determine the antiulcerogenicity of the flavonoid fraction (ethyl acetate extract) of Erica andevalensis Cabezudo-Rivera on gastric ulceration induced by different experimental models. Oral treatment with the ethyl acetate extract and the major flavonoid (myricetin 3-O-ᴅ-galactoside) were found to be effective to prevent gastric ulceration induced by cold-restraint stress in rats . Statistically significant ulcer index values with respect to the control group were observed. Mucus content was not increased although it was accompanied by an increase in proteins and hexosamines. In pyloric-ligated animals flavonoids showed a significant reduction in the number and severity of the ulcers. Under the same conditions acidity did not decrease with the flavonic extract and myricetin 3-O-ᴅ-galactoside significantly as compared to control. Gastric ulcers induced by oral administration of absolute ethanol were reduced by pretreatment with the flavonoid extract of doses from 125 to 250 mg/kg and the isolated flavonoid of 25 mg/kg p.o. However neither the flavonic extract nor the isolated flavonoid induced changes in the amount and glycoprotein content of gastric mucus.


1993 ◽  
Vol 265 (3) ◽  
pp. G418-G422 ◽  
Author(s):  
J. F. Brown ◽  
A. C. Keates ◽  
P. J. Hanson ◽  
B. J. Whittle

The effect of nitric oxide (NO) donors on the release of mucus from a suspension of isolated gastric cells was investigated by using an enzyme-linked immunosorbent assay for rat gastric mucin. Isosorbide dinitrate (ISDN, 0.1-2 mM) produced a dose-related stimulation of mucus secretion, without affecting the viability of the isolated cells as determined by trypan blue exclusion or acid phosphatase release. In a comparable concentration range to that stimulating mucus release, ISDN elevated the guanosine 3',5'-cyclic monophosphate (cGMP) content of cell suspensions enriched with mucous cells. The nitrosothiol S-nitroso-N-acetylpenicillamine (0.3 mM), which spontaneously liberates NO, likewise stimulated mucus release, and this action was blocked by 10 microM oxyhemoglobin, which scavenges NO. Nitroprusside (1 mM), dibutyryl cGMP (0.01-1 mM), and the cGMP phosphodiesterase inhibitor M & B 22948 (0.1 mM) also increased mucus release. Thus generators of NO stimulate mucus secretion by rat gastric mucosal cells, which may reflect the elevation of intracellular cGMP. These findings, along with the presence of NO synthase in the gastric epithelial cells, suggest an effector role for NO in mediation of gastric mucus release.


1986 ◽  
Vol 81 (2) ◽  
pp. 30-33 ◽  
Author(s):  
L. David Waterbury ◽  
Janette M. Mahoney ◽  
Tina M. Peak ◽  
Ronald G. Cohn ◽  
Gabriel L. Garay

2016 ◽  
Vol 2016 ◽  
pp. 1-5
Author(s):  
U. Akpamu ◽  
H. O. Otamere ◽  
I. O. Ernest-Nwoke ◽  
C. N. Ekhator ◽  
U. C. Osifo

Gastric ulcer has shown association with changes in sex hormones, with impact exacerbated in males. Also, males are known to be more exposed to ulcer risk factors. This study investigates the effect of testosterone on indomethacin induced gastric ulcers in adult female rats. Eighteen female rats (225 ± 25 g body weight) were randomly assigned to 3 groups under standard laboratory condition. After acclimatization, animals fasted for 40 hrs but were given water ad libitum. Group A served as control while group B served as the ulcer control, in which ulcer was induced without treatment using indomethacin (40 mg/kg single orally dose). Group C was pretreated with testosterone (1 mg/kg IM) eight hours before ulcer induction. Eight hours after ulcer induction, animals were sacrificed and the stomach was harvested for analysis. Results showed a significant reduction in mucus content in groups C (0.79±0.11 g) and B (0.87±0.02 g) compared to A (1.11±0.03 g). Gastric mucus pH was significantly acidic in group B (4.40±0.55) compared to C (5.20±0.45) and A (5.80±0.45). There was a significantly higher ulcer index in group B (4.60±0.55 mm) compared to C (3.60±0.89 mm) and testosterone pretreatment resulted in a 21.74% ulcer inhibition. Although weak, the findings suggest that testosterone might protect the gastric mucosa against NSAIDs in females.


2021 ◽  
Vol 64 (1) ◽  
Author(s):  
Ji Hwan Lee ◽  
Do Hwi Park ◽  
Sanghyun Lee ◽  
Hye Jin Seo ◽  
Shin Jung Park ◽  
...  

AbstractThe prevalence of gastritis in South Korea is rapidly increasing owing to the prevalence of Helicobacter pylori infection and fast eating habit. The usual treatment for acute gastritis following a long intake of non-steroidal anti-inflammatory drugs (NSAIDs) or alcohol is to stop the causal factors. Metronidazole and lansoprazole are recommended for the treatment of H. pylori infection gastritis. Omeprazole a proton pump inhibitor, is used to decrease gastric acid production. However, owing to the side effects and refractoriness of the drug, a safe and efficient treatment is required. Plant-derived phytochemicals have emerged as novel agents against chronic disorders. In this study, firstly, to explore the potential of pharmacological activities, including efficacy and mechanisms of Cinnamomum cassia against gastritis, a literature review was performed based on 20 studies out of a total of 749 records obtained using a search strategy. From the literature review, the therapeutic targets of C. cassia extract and cinnamaldehyde, a compound of C. cassia, were found to be related with NFκB activity, and their signaling pathway were verified by experiments. C. cassia extract plays a role in protection of gastric ulcers induced in four ways (immersion stress-induced, ethanol-induced, hydrochloric acid-induced, or NSAIDs-induced ulcer). None of the clinical studies on C. cassia extracts or compounds met our criteria. When the standardized extract of C. cassia (ECC) was orally administered repeatedly to Beagle Dog for 4 weeks, no toxicologically harmful changes were observed. Therefore, under the test condition, the no observed adverse effect level (NOAEL) of ECC was judged to be 1000 mg/kg/day for both sexes, and no toxic target organ was observed. Administration of ECC in the Sprague–Dawley rat model of acute gastric injury caused by indomethacin administration significantly increased gastric mucus volume. Administration of ECC in the acute gastric injury model caused by indomethacin administration is considered effective in improving gastric injury. However, research and efforts to develop a reliable ‘standardization of natural drugs’ by establishing the best quality evaluation system are limited. Despite the pharmacological potential of ECC, further well-designed experimental studies such as in vitro, in vivo, and clinical trials are required to validate these findings and the underlying mechanisms of ECC.


2018 ◽  
Vol 24 (18) ◽  
pp. 2002-2011 ◽  
Author(s):  
Koji Takeuchi ◽  
Kikuko Amagase

Endogenous prostaglandins (PGs), produced from arachidonic acid by the two isoforms of cyclooxygenase (COX), play a pivotal role in maintaining mucosal integrity by modulating various functions of the gastrointestinal (GI) tract, and PGE2 is most effective in these actions. The PGE2 receptor is classified into 4 specific G-protein coupled subtypes, EP1-EP4, and their distribution accounts for the multiple effects of this prostanoid. PGE2 prevents acid-reflux esophagitis and indomethacin-induced gastric lesions through EP1 receptors, while endogenous PGs protect the stomach against cold restraint stress mediated by mainly PGI2/IP receptors and partly EP4 receptors. PGE2 also exhibits a protective effect against acid-induced duodenal damage and indomethacin-induced small intestinal lesions mediated by EP3/EP4 receptors; these effects in the stomach, duodenum, or small intestine are associated functionally with inhibition of gastric contraction (EP1), stimulation of duodenal HCO3 - secretion (EP3/EP4), or suppression of bacterial invasion due to the inhibition of intestinal motility (EP4) as well as stimulation of mucus secretion (EP3/EP4), respectively. PGE2 also prevents ischemiainduced enteritis and dextran sulfate sodium-induced colitis mediated by EP4 receptors, and the protective mechanisms may be related to the stimulation of mucus secretion and the down-regulation of immune response, respectively. Furthermore, PGE2 shows a healing-promoting effect on gastric ulcers and small intestinal lesions through the up-regulated expression of vascular endothelial growth factor (VEGF) and stimulation of angiogenesis via the activation of EP4 receptors. Finally, COX-1 is mainly responsible for the production of endogenous PGs involved in mucosal protection, while COX-2 is mainly responsible for those involved in the healing of gastric ulcers or small intestinal lesions. These findings contribute to future development of new strategies for the treatment of GI diseases.


2008 ◽  
Vol 134 (4) ◽  
pp. A-704
Author(s):  
Katsunori Iijima ◽  
Kazuhiko Ishihara ◽  
Masaaki Ogawa ◽  
Tomoyuki Koike ◽  
Shuichi Ohara ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document